MFS Blended Research Mid Cap Eq R6 holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
MFS Blended Research Mid Cap Equity Fund R6 BMSYX
- NAV / 1-Day Return $17.53 / +0.11 %
- Fund Size $3.5B
- Adjusted Expense Ratio 0.510%
- Net Expense Ratio 0.500%
- Fee Level: Distribution Low
- Share Class Type Retirement, Large
- Morningstar Category Mid-Cap Blend
- Equity Style Box (Funds) Mid Blend
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 0.67%
- Turnover Ratio 51%
Morningstar’s Analysis BMSYX
Will BMSYX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Illumina Inc | 2.18 | 69M | Healthcare |
Okta Inc Class A | 2.10 | 66M | Technology |
Humana Inc | 1.78 | 56M | Healthcare |
Northern Trust Corp | 1.76 | 56M | Financial Services |
DexCom Inc | 1.73 | 55M | Healthcare |
Westinghouse Air Brake Technologies Corp | 1.69 | 53M | Industrials |
Aramark | 1.67 | 53M | Industrials |
Ameriprise Financial Inc | 1.67 | 53M | Financial Services |
Teradyne Inc | 1.65 | 52M | Technology |
Hewlett Packard Enterprise Co | 1.57 | 49M | Technology |